INDIRA VOGEL: Open Payments
NPI 1790459360 · SAN JUAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 65 payments from 18 companies in 2025. Trend: 2023 $1,072 · 2024 $1,036 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $267 |
| GlaxoSmithKline, LLC. | 11 | $202 |
| PFIZER INC. | 5 | $98 |
| Amgen Inc. | 5 | $80 |
| Novo Nordisk Inc | 4 | $78 |
| Paratek Pharmaceuticals, Inc. | 4 | $65 |
| ABBVIE INC. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Exact Sciences Corporation | 3 | $54 |
| Lilly USA, LLC | 2 | $45 |
Products named: TRELEGY ELLIPTA, FARXIGA, BREZTRI, NUZYRA, ELIQUIS, Kerendia, Cologuard Collection Kit, OTEZLA.
Industry payments across TX — which companies pay providers there.
